Journal News

Which eight escaped the Scientific 16?

JBC Methods Madness: Round 1 recap
Anand Rao
March 22, 2021

The Journal of Biological Chemistry’s Methods Madness tournament started off with a bang as last year’s finalist, #TeamMassSpec, faced off against the tournament newcomer #TeamFRET. #TeamFRET fought valiantly, but their supporters’ energy just didn’t transfer into votes. Meanwhile, #TeamMassSpec supporters turned up in SPECTRAcular numbers, pushing their team to the next round.

X-ray crystallographers around the world are rejoicing after #TeamXRC’s victory over #TeamImmuno. Votes proved to be too nonspecific for #TeamImmuno, whose supporters were unable to band together to provide support for their team. #TeamXRC advances to the next round while #TeamImmuno fades into the background.

#TeamCryo iced their competition, leaving #TeamMachine frozen in their tracks. Despite strategic support from #TeamMassSpec, it seems too many #TeamMachine supporters had their heads in the cloud, because they couldn’t find the algorithm needed to execute a win against the defending champion. #TeamCryo will move on to the Energetic Eight, where they will have a tough matchup against #TeamCRISPR.

In this cellular showdown, #TeamiPSC lacked the factors necessary to differentiate from the other losers of the week. In contrast, #TeamLiveCell was unphased by the pressure, shining bright in the win they captured. #TeamLiveCell has #TeamOmics in their frame as they focus on the next round.

#TeamPCR copied last year’s success to defeat #TeamChroma and advance to the next round. Supporters of #TeamChroma couldn’t match the flow rate of #TeamPCR voters, leaving #TeamChroma stuck in a stationary phase while their opponent mobilized. #TeamPCR will look to amplify their success with a win over #TeamMassSpec in the next round.

Resonating with their supporters, #TeamNMR put forth a dynamic performance to secure their second #JBCMethodsMadness win in as many years. Living up to their name, #TeamCloning replicated last year’s performance where they also lost against #TeamNMR in the first round. Perhaps they’ll find the winning recombination next year!

#TeamCRISPR excised #TeamSuperRes in the first round of the tournament and will move on to the next round. Despite their resolution to make it further this year, the win that #TeamSuperRes pictured was never fully deconvolved. #TeamCRISPR has their work cut out for them, facing off against the defending champion #TeamCryo.

Seq-ing a win in their tournament debut, #TeamOmics analyzed their competition and came out victorious. Seemingly unable to shed light on a winning formula, #TeamOpto failed to excite their supporters, resulting in their second tournament loss in as many years. Next, #TeamOmics will match up against #TeamLiveCell in the Energetic Eight round.

Round 2: The Energetic Eight

Monday, March 22

12 p.m. Eastern – #TeamNMR vs. #TeamXRC

Tuesday, March 23

12 p.m. Eastern – #TeamPCR vs. #TeamMassSpec

Wednesday, March 24

12 p.m. – #TeamLiveCell vs. #TeamOmics

Thursday, March 25

12 p.m. – #TeamCryo vs. #TeamCRISPR

 

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Anand Rao

Anand Rao is the former ASBMB publications strategy manager.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Unraveling the language of histones
Profile

Unraveling the language of histones

Nov. 20, 2025

Philip Cole presented his research on how posttranslational modifications to histones are involved in gene expression and how these modifications could be therapeutically targeted to treat diseases like cancer.

How Alixorexton could transform narcolepsy treatment
News

How Alixorexton could transform narcolepsy treatment

Nov. 18, 2025

A new investigational drug, alixorexton, targets the brain’s orexin system to restore wakefulness in people with narcolepsy type 1. Alkermes chemist Brian Raymer shares how molecular modeling turned a lab idea into a promising phase 3 therapy.

Phosphatases and pupils: A dual legacy
Profile

Phosphatases and pupils: A dual legacy

Nov. 13, 2025

Yale professor Anton Bennett explores how protein tyrosine phosphatases shape disease, while building a legacy of mentorship that expands opportunity and fuels discovery in biochemistry and molecular biology.

Extracellular vesicles offer clues to cattle reproduction
Journal News

Extracellular vesicles offer clues to cattle reproduction

Nov. 11, 2025

Extracellular vesicles from pregnant cattle support embryo development better than laboratory models, highlighting their potential to improve reproductive efficiency in bovine embryo cultures. Read more about this recent MCP paper.

Proteomics reveals protein shifts in diabetic eye disease
Journal News

Proteomics reveals protein shifts in diabetic eye disease

Nov. 11, 2025

Using proteomics, researchers identified protein changes in eye fluid that mark diabetic retinopathy progression and may serve as biomarkers for vision-threatening complications. Read more about this recent MCP paper.

Protein modifications drive lung cancer resistance
Journal News

Protein modifications drive lung cancer resistance

Nov. 6, 2025

New assay enriches protein modifications in a single process, enabling detection of key changes in drug-resistant lung cancer cells that may guide future therapies.